Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)

Warning LetterOpen

United StatesIssued Jul 30, 2018

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations0

Issue DateJul 30, 2018

Product TypeOther

StatusOpen

Letter Details

Firm: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Location: United States
FEI Number: N/A
Country: United States
Issue Date: July 30, 2018
Issuing Office: N/A
Product Type: Other
Status: Open

Summary

Based on limited metadata with no full letter text available, this warning letter was issued to Medtronic Inc.'s Cardiac Rhythm and Heart Failure division in July 2018, indicating regulatory concerns with their cardiac or heart failure-related medical devices or products. While the specific nature of the violations cannot be determined from the available metadata, the warning suggests FDA compliance issues within the cardiac device category under an unspecified issuing office. Without access to the complete letter text, the precise regulatory violations and their scope remain undetermined.

Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) FDA Warning Letter, July 30, 2018